Medical Director, Duke Inpatient Diabetes Management
Department / Division
Medicine / Medicine-Endocrinology and Metabolism
Durham, NC 27710
Not accepting new patients
Safe use of intravenous insulin and subcutaneous insulin, all aspects of diabetes in the hospital, obesity, metabolomics, metabolic syndrome
Lillian Lien, MD is an Assistant Professor in the Duke Department of Medicine, a faculty member of the Division of Endocrinology, Metabolism and Nutrition, and a faculty member of the Sarah W. Stedman Nutrition and Metabolism Center. Lillian completed Internal Medicine Residency and Endocrinology Fellowship training at Duke University Medical Center. She has long had an interest in quantitative research, beginning with her undergraduate work at Harvard University in Biomedical Engineering. Throughout her medical career, she has devoted her efforts to clinical research and translational projects. In 2001, she received the Barton Haynes Research Support Award for her innovative work in optimizing the safe administration of intravenous insulin. Her other research priorties focus on obesity and metabolism, with a specific interest in the metabolic syndrome and the link between adipocytokines and insulin resistance. She is a key member of the STEDMAN Project team and is involved in wide-ranging project issues from project design to supervising and instructing junior staff. She also received the 2006 Haynes Early Career Research Grant for junior faculty in the Duke Department of Medicine.
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
Lien, LF; Brown, AJ; Ard, JD; Loria, C; Erlinger, TP; Feldstein, AC; Lin, PH; Champagne, CM; King, AC; McGuire, HL; Stevens, VJ; Brantley, PJ; Harsha, DW; McBurnie, MA; Appel, LJ; Svetkey, LP. Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome. Hypertension. 2007;50:609-616. (2007) Abstract
Davis, ED; Harwood, K; Midgett, L; Mabrey, M; Lien, LF. Implementation of a new intravenous insulin method on intermediate-care units in hospitalized patients. The Diabetes Educator. 2005;31:818-823. (2005) Abstract
Haqq, AM; Lien, LF; Boan, J; Arlotto, M; Slentz, CA; Muehlbauer, MJ; Rochon, J; Gallup, D; McMahon, RL; Bain, JR; Stevens, R; Millington, D; Butler, MD; Newgard, CB; Svetkey, LP. The Study of the Effects of Diet on Metabolism and Nutrition (STEDMAN) weight loss project: Rationale and design. Contemporary Clinical Trials. 2005;26:616-625. (2005) Abstract
Lien, LF; Feinglos, MN. Protease inhibitor-induced diabetic complications : incidence, management and prevention. Drug Safety. 2005;28:209-226. (2005) Abstract
Lien, LF; Spratt, SE; Woods, Z; Osborne, KK; Feinglos, MN. Optimizing hospital use of intravenous insulin therapy: improved management of hyperglycemia and error reduction with a new nomogram. Endocrine Practice. 2005;11:240-253. (2005) Abstract
Lien, LF; Angelyn Bethel, M; Feinglos, MN. In-hospital management of type 2 diabetes mellitus. Medical Clinics of North America. 2004;88:1085-xii. (2004) Abstract
Lien, LF; Whitson, HE; Grant, AG; McNeill, DB. Multiple endocrine neoplasia type 1 manifesting with chronic and persistent diarrhea. Endocrine Practice. 2004;10:83-84. (2004) Abstract
Robinson, RA; Stewart, SF; Myers, MR; Lien, LF; Rinaldi, JR; Swisher, JL; Drasner, K. In vitro modeling of spinal anesthesia. A digital video image processing technique and its application to catheter characterization. Anesthesiology. 1994;81:1053-1060. (1994) Abstract